Our mission is to be a global leader in generics and biopharmaceuticals, improving the lives of patients across the world.
In a complex world, Teva's mission is simple: to improve the lives of patients across the globe. We believe that everyone should have access to quality medicines whether it be for managing disease, fighting infections, or simply improving overall health.
We are proud that since Teva’s establishment in 1901, healthcare providers together with patients and caregivers have been using our accessible generic and innovative products. Today, our portfolio of around 3,500 products is among the largest of any pharmaceutical company in the world. Nearly 200 million people in 60 countries benefit from one of Teva's quality medicines every day. We invest in research and development of generic medicines and biopharmaceuticals, carrying on the legacy of more than a century of finding new ways to help patients improve their lives. This defines our values as a company and characterizes how we do business and approach medicine.
Around 200 million people worldwide take one of our medicines every day. In the United States, where Teva is the leading generic pharmaceutical company, one out of every nine prescriptions is filled by a Teva product. In the UK it is one out of every six and in Canada it is one out of every six. In addition, many prescription medications made by other companies include active pharmaceutical ingredients produced by Teva.
While Teva focuses on developing, personalizing and making treatments accessible for patients across a wide range of therapeutic areas, we have several key areas of focus where our specialty research and development concentrates its efforts. There are treatments for respiratory, pain, migraine and headache, movement and neurodegenerative disorders, and oncology.
The Montana Psychiatry Conference makes every attempt to provide accurate and timely content available for users. Neither MPC nor third-party content providers are responsible or liable for any such content, including advertising, products or other materials available through third party sites.
The Montana Psychiatry Conference board has decided that due to the recent surge in COVID cases, the hospital situation in Montana, and travel restrictions placed on our speakers by their university-hospital systems, we will be moving the 2021 MPC to a virtual only event.